Judging from your comments you don't really think much on this topic do you?....extrapolating cardiocel revenues need something like 50% revenue growth quarter on quarter to dodge a capital raising.....A cap raise of say another $20m changes valuations completely thats why the share price has been sliding for the past year and a half....I will watch the splits for valve repair surgeries done..... off topic MENA could be an interesting geographic region as I would be hesitant on porcine based patch sales in this region....interesting thought experiment!.....
Quarterly, page-70
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |